MPD Chemicals Recapitalizes in Support of Growth
TREVOSE, Pa., Aug. 9, 2012 /PRNewswire-iReach/ — Global Healthcare Partners LLC (“GHP”) and Addison Capital Partners (“ACP”), in partnership with the existing management team, are pleased to announce the completion of the recapitalization of MPD Chemicals (“MPD” or the “Company”).
Based in Trevose, PA, MPD manufactures specialty chemicals with expertise in multiple technical areas including complex organic synthesis, unique monomers, polymer development, organosilicone chemistries and stable isotope labeling, which are primarily used in the manufacture of medical devices, industrial materials, pharmaceuticals and other niche applications.The Company is comprised of three distinct business units: Monomer-Polymer and Dajac Labs, Silar Laboratories and IsoSciences. MPD has three R&D and production facilities in Trevose, PA, King of Prussia, PA and Scotia, NY, coupled with ISO 9001 scale up lab and main reactor campus near Wilmington, NC.
With the recapitalization and new investor base consisting of industry and private equity executives, MPD plans to accelerate sales growth penetration using the group’s collective and extensive relationships, network and expertise in the Company’s existing end markets and customer base. MPD will also look to expand into additional chemistry and technical arenas creating a fully integrated provider of solutions for a number of key and growing markets.
“MPD has built a reputation as a leading, fully integrated, critical supplier of final, complex and often novel materials.” said GHP Principal Doug Rogers. “GHP and ACP principals are excited to partner with Dr. Bell and his team and are committed to enhancing shareholder value and supporting MPD’s next phase of growth.”
“Continuing MPD’s exceptional growth is dependent on finding the right partners in both end application clients and its investor base. The management at MPD is delighted to add GHP as partners and relishes the opportunities they bring to our organization. We all look forward to many more years extending the current growth of MPD Chemicals.” added Stephen Bell, CEO.
About MPD Chemicals:
MPD Chemicals is a US based manufacturerof specialty chemicals with expertise in multiple technical areas including complex organic synthesis, unique monomers, polymer development, organosilicone chemistries and stable isotope labeling. The Company is comprised of three distinct manufacturing units: Monomer-Polymer and Dajac Labs, Silar Laboratories, and IsoSciences. MPD services a variety of industrial and commercial markets including medical devices (e.g. ophthalmic lenses, wound care applications, implantable device coatings and dental resins), pharmaceuticals, adhesives and various industrial materials.
With a dedicated team of 63 employees (17 with advanced degrees, including 10 Ph.D. chemists) in R&D, engineering, quality assurance and manufacturing, MPD collaborates with its customers’ to develop novel materials for customer application needs by leveraging cross-disciplinary expertise with operational strength in scaling from milligram to metric ton batches.
MPD is headquartered in Trevose, Pennsylvania and operates three R&D and production facilities in PA and NY, coupled with an ISO-9001:2008 certified scale up lab and main reactor campus near Wilmington, North Carolina.For more information, please visit us at www.mpdchemicals.com.
About Global Healthcare Partners LLC:
GHP is a group of healthcare industry and private equity executives that invest in the lower middle-market. The group typically invests between $10 million and $50 million in equity to sponsor buyouts, growth initiatives, corporate spin-offs and recapitalizations in the health care sector. The group has been investing together and through predecessor groups for over 25 years and has a preeminent track record in health care buyouts.
About Addison Capital Partners:
ACP is a private equity investment firm that seeks out partnerships with owners and operators of “smaller” middle market growth companies to provide liquidity, growth capital and management resources to grow and build exceptional enterprises.ACP looks to create true partnerships with exceptional businesses typically in value-added distribution, with manufacturer/distributors or niche manufacturing and business service companies. For more information, please visit us at www.addisoncapitalpartners.com.
For more information on this transaction, please contact Brian Miller at email@example.com (561)835-4041
Press release submitted by online press release distribution service Submit Press Release 123
Media Contact: Brian Miller, MPD Chemicals, (561)835-4041, firstname.lastname@example.org
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE MPD Chemicals